This paper provides a practical framework for individualizing the resumption of anticoagulation after hemorrhage in the absence of evidence-based guidelines.
May guide individualized anticoagulation resumption after hemorrhage where guidelines are absent; leaves open the need for prospective validation.
Most patients who suffer a hemorrhage while on long-term anticoagulant therapy continue to be at risk of thrombosis. Physicians often need to reconsider the need for anticoagulation in view of the risk of recurrent bleeding, and when anticoagulation needs to be resumed, they must also consider the timing and strategy. Since there are no evidence-based guidelines for these situations, the authors of this paper offer a practical framework for individualizing the resumption of anticoagulation after hemorrhage.
No takes yet. Share an insight, caveat, or question.
Colantino et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: